CRIS Current Research Information System

GADDI, ANTONIO VITTORINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.123
NA - Nord America 6.182
AS - Asia 5.632
SA - Sud America 385
AF - Africa 284
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 8
Totale 31.631
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.816
US - Stati Uniti d'America 6.128
SG - Singapore 1.583
CN - Cina 1.580
DE - Germania 1.538
GB - Regno Unito 1.423
VN - Vietnam 1.236
NL - Olanda 772
SE - Svezia 516
UA - Ucraina 506
FR - Francia 446
HK - Hong Kong 350
IN - India 309
RU - Federazione Russa 290
BR - Brasile 272
IE - Irlanda 166
JP - Giappone 145
CH - Svizzera 144
KR - Corea 120
ZA - Sudafrica 110
FI - Finlandia 93
EE - Estonia 86
CI - Costa d'Avorio 55
PL - Polonia 55
BE - Belgio 48
AR - Argentina 46
SC - Seychelles 43
ES - Italia 38
TR - Turchia 35
BG - Bulgaria 34
TG - Togo 34
GR - Grecia 32
TH - Thailandia 31
CA - Canada 29
IQ - Iraq 29
BD - Bangladesh 28
RO - Romania 27
TW - Taiwan 24
AL - Albania 22
JO - Giordania 22
ID - Indonesia 21
MX - Messico 20
PH - Filippine 20
SA - Arabia Saudita 18
PK - Pakistan 17
AU - Australia 15
EC - Ecuador 14
AT - Austria 13
CL - Cile 13
CO - Colombia 11
EG - Egitto 10
HR - Croazia 10
MY - Malesia 10
MA - Marocco 9
UZ - Uzbekistan 9
PE - Perù 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
DZ - Algeria 6
LB - Libano 6
MC - Monaco 6
NO - Norvegia 6
PY - Paraguay 6
EU - Europa 5
HU - Ungheria 5
IR - Iran 5
LU - Lussemburgo 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
KE - Kenya 4
KZ - Kazakistan 4
OM - Oman 4
RS - Serbia 4
SI - Slovenia 4
UY - Uruguay 4
BY - Bielorussia 3
GE - Georgia 3
IL - Israele 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
KH - Cambogia 2
LT - Lituania 2
MN - Mongolia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GN - Guinea 1
GY - Guiana 1
JM - Giamaica 1
Totale 31.622
Salva come PNG Salva come JPEG
Città #
Milan 1.233
Southend 1.199
Singapore 997
Rome 941
Ashburn 525
Fairfield 498
Chandler 471
Santa Clara 416
Hefei 381
Naples 381
Frankfurt am Main 359
Jacksonville 352
San Jose 351
Hong Kong 338
Turin 294
Bologna 274
Princeton 270
Wilmington 261
Ho Chi Minh City 252
Seattle 239
Woodbridge 238
Florence 236
Hanoi 227
Dong Ket 195
Ann Arbor 189
Padova 186
Düsseldorf 172
Houston 168
Palermo 164
Cambridge 160
Dublin 160
Boardman 153
Bari 148
Tokyo 135
Lauterbourg 131
Verona 126
Nanjing 121
Beijing 118
Westminster 117
Seoul 106
Catania 96
Genoa 93
Los Angeles 91
Berlin 88
Helsinki 83
Buffalo 79
Brescia 75
Parma 71
Saint Petersburg 69
Cagliari 60
Medford 59
Bremen 58
Modena 58
Abidjan 55
Dallas 52
Pescara 52
Mülheim 51
Perugia 49
Venice 44
Monza 43
Shenyang 42
Jinan 41
Mahé 41
Hebei 40
Haiphong 39
Brussels 38
Nanchang 38
Vicenza 38
Da Nang 36
Dearborn 35
Reggio Emilia 35
The Dalles 35
Bern 34
Lomé 34
Shanghai 34
Livorno 33
Sofia 32
Trento 32
New York 31
Bengaluru 30
Ancona 29
Changsha 29
San Diego 29
Warsaw 29
Guangzhou 28
Bergamo 27
São Paulo 27
Trieste 27
Montesilvano Marina 25
Taranto 25
Mountain View 23
San Venanzo 23
Amman 22
Como 22
Cosenza 22
Redwood City 22
Council Bluffs 21
Meda 21
Orem 21
Paris 21
Totale 15.819
Salva come PNG Salva come JPEG
Nome #
La fame d’amore: un bambino che sta bene non piange. 13.203
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report 1.716
Assessment of the health status in the Massa Lombarda cohort: a preliminary description of the program evaluating cardio-cerebro-vascular disease risk factors and quality of life in an elderly population. 270
Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy 211
Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. 210
Wath are the major risk factors for type II diabetes development in the historical cohort of the Brisighella heart study? A 16-years follow-up 206
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial. 194
Treatment of massive hypertriglyceridemia resistant to PUFA and fibrates: a possible role for the coenzyme Q10? 186
A comparison study of Lp(a) plasma levels distributions between normo- and hypertensive subjects with high BMI. 184
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up 181
Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related with the lipid oxidative damage: the EUROLIVE Study. 180
Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. 179
Epidemiologia delle malattie cerebrovascolari. 179
Sources of variabilità of plasma HDL-cholesterol levels. 179
Linkage disequilibrium patterns and tagSNP transferability among European populations. 177
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates. 174
Software per l'identificazione automatica delle iperlipoproteinemie genetiche 174
Effects of a new low dose soy protein β-sitosterol association on plasma lipid levels and oxidation 172
Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone. 172
Relative role of major risk factors for Type 2 Diabetes development in the historical cohort of the Brisighella Heart Study: an 8-years follow-up. 171
A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. 171
Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial. 170
Prevalenza e determinati clinico-laboratoristici della sindrome metabolica in un campione di soggetti in età geriatrica: il Brisighella Heart Study 170
Prevalence of metabolic syndrome in working population: preliminary results fo a campaign of cardiovascular risk screening 170
Development of an UHPLC-diode arrays detector (DAD) method for the analysis of polydatin in human plasma 169
Proteine della Soia. Effetti metabolici e ruolo nella prevenzione cardiovascolare 164
Efficacia della supplementazione dietetice con fibre solubili nelle gestione del rischio delle malattie cardiovascolari di pazienti affetti da SM: un trial clinico randomizzato open label di un anno 161
Metabolic Syndrome prevalence in Italy. 161
REVERSAL and PROVE-IT: are clinically oriented trials really better than "pure" scientific studies? 157
Elevated circulating LDL phenol levels in men who consumed virgin rather than refined olive oil are associated with less oxidation of plasma LDL. 157
Iperlipoproteinemia familiare combinata: complicanze cardiovascolari e cerebrovascolari 151
Osservazioni clinico sperimentali su possibili relazioni tra andamento dei valori sierici di creatinina kinasi e colesterolo LDL in pazienti asintomatici con ipercoelsterolemia ed elevati livelli di CPK in corso di terapia con statine. 151
A dietary education program involving the general population balances the effects of menopause on cardiovascular risk factors and metabolic syndrome incidence: data from the Brisghella Heart Study 150
Effect of olive oils on biomarkers of oxidative DNA stress in Northern and Southern Europeans. 149
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor 148
Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. 147
Novel mutation in the ApoB Gene (Apo B-15.56): A Case Report. 146
BlueC@rdio 145
The influence of statin medications on Prostate Specific Antigen levels. 144
Criteri di appropriatezza clinica, tecnologica e strumentale nell'assistenza alle malattie del sistema cardiovascolare 144
Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride. 144
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Heart Study. 143
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. 142
Effect of a dietary education program on plasma lipid level in a rural setting: the Brisighella Heart Study 140
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients 138
Physical activity and cardiovascular disease mortality: the Brisighella heart study 137
Attività fisica e aterosclerosi: i dati di Brisghella 137
Otoscopic findings in hypercholesterolemic subjects 136
Massa Lombarda Project (Prevention and control of cardiovascular diseases: Instant Individual Definition and Bluc@ardio Project) 134
Physical activity, exercise and cardiovascular health 133
Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project 133
What herbalists suggest to our diabetic patients in order to improve their glycaemic control? Evaluation of scientific evidences and potential risks. 132
Effect of Sulodexide on Albuminuria, NAG Excretion and Glomerular Filtration Response to Dopamine in Diabetic Patients. 132
Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. 131
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered. 131
Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept. 131
Confronto di due algoritmi diagnostici nella strima della prevalenza della sindrome metabolica in soggetti in età geriatrica e nella popolazione gnerale: Il Brisighella Heart Study. 130
Observation of possibly relations between trend of CPK levels and LDL cholesterol in patients with hypercholesterolemia and asymptomatic primary high level of creatinechinase under statin therapy 130
Moderate consumption of olive oil by healthy European men reduces systolic blood pressure in non-Mediterranean participants. 128
A nutraceutical based approach to reduce cholesterolemia in patients previously intolerant to more than a statin: a pilot study. 128
Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. 128
Treatment of peripheral obstructive artery disease: a battle that could be winned also with drugs? [Trattamento dell'arteriopatia obliterante degli arti inferiori: Una battaglia che può essere vinta anche con i farmaci?] 127
Primary variation in serum HDL-cholesterol levels: an independent cardiovascular risk factor in healthy adults? 125
Complementary and alternative medicine for hypertension. What evidence is there for herbalist suggestions? 125
Modification of the dietary habits in the Brisighella Heart Study 125
Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. 125
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study. 124
Gender specific haemodinamic and metabolic effects of a sequential training program on hypertensive overweight patients. 122
Assocaition between hyperCKPemia and hypercholesterolemia in general population: casual phenotype or genic cluster? 122
Regression of atherosclerosis after one year of treatment with low dosed rosuvastatin: the role of patient selection. 122
Estimating the burden of hyperlipidemia in a hypertensive ambulatory population 121
Plasma lipid effects of corn oil and extra-virgin olive oil in hypercholesterolemic subjects: a randomized, controlled trial. 120
Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardio-vascular disease: response to Beishuizen et al. 120
Physical activity trend in a rural population submitted to a nutritional program: the Brisighella Heart Study 119
MMP-2, MMP-9 and their inhibitors in FCH, MS, FCH+MS and control subjects: a comparison study. 119
Brisghella Heart Study (BHS): ipertensione ed obesità. 119
Piano Regionale della Prevenzione (2005-2008; volume 44) 118
Main predictors of metabolic syndrome and type 2 diabetes development in the historical cohort of the Brisighella Heart Study: a 16 years follow-up. 118
Metabolic Effects of Pioglitazone and Rosiglitazone in patients with diabetes and metabolic syndrome treated with Glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. 118
Incontro sull'eccellenza didattica tra Dodenti della Facoltà di Medicina del Karolinska Institute e dell'Università di Bologna 116
Otoscopic examination: a diagnostic contribution for atherosclerotic disease? 116
eHealth: uno strumento di prevenzione cardiovascolare 115
EUROLIVE 114
Non-pharmacological control of plasma cholesterol levels. 112
Causes of statin interruption by hyperlipidaemic patients: the result of survey on 218 consecutive patients. 112
Combining natural treatments to reach lipid target in metabolic syndrome patients: A randomized clinical trial 111
The relevance of soluble fibre dietary supplement in cardiovacular disease risk menagement of patients affected by metabolic syndrome (MS): a 1-year, open label, randomized clinical trial. 111
Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial. 109
Role of olive oil in the health: results form the Eurolive Study. 108
Non conventional cardiovascular risk factors distribution in FCH, MS, FCH+MS and control subjects: towards a full disease characterization. 108
Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial. 107
Strumenti diagnostici per l’identificazione delle iperlipoproteinemie a base genetica. 106
Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension. 106
Progetto Best Practice - Ipercolesterolemia (cfr sito) 105
Effect of a sequential training program on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome 105
Consapevolezza, trattamento e controllo della pressione artersiosa e modificazioni temporali nell'impiego dei farmaci antiipertensivi. 104
CARDIOVASCULAR DISEASE RISK PERCEPTION IN PATIENTS AFFECTED BY FAMILIAL HYPERLIPIDAEMIAS IN SPECIALIST SETTING 103
Obesity related health risk and social cost. 103
Metabolic syndrome and prevalence of instrumental atherosclerosis or its clinical complications in 1000 subjects affected by different forms of familial hyperlipoproteinemia. 103
Practical reccomendations for Familial Combined Hyperlipidemia diagnosis and management: an update. 103
Totale 28.727
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021740 0 0 0 0 0 0 0 0 0 148 157 435
2021/20222.152 198 88 134 134 210 145 50 152 87 119 456 379
2022/20232.684 302 317 148 346 148 168 123 187 360 136 285 164
2023/20243.543 93 210 122 154 164 230 194 168 242 635 579 752
2024/20259.729 870 1.231 840 823 1.195 665 1.092 640 467 671 444 791
2025/20267.543 717 1.158 919 664 745 814 591 435 1.036 464 0 0
Totale 31.943